Prostatis Group’s ConocoPhillips COP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Buy
3,705
+1,485
+67% +$176K 0.09% 123
2026
Q1
$293K Buy
+2,220
New +$246K 0.08% 143
2024
Q3
Sell
-1,946
Closed -$223K 132
2024
Q2
$223K Sell
1,946
-832
-30% -$101K 0.08% 136
2024
Q1
$354K Buy
2,778
+682
+33% +$77.8K 0.13% 108
2023
Q4
$243K Sell
2,096
-35
-2% -$4.09K 0.1% 115
2023
Q3
$267K Buy
+2,131
New +$247K 0.13% 94

Other funds holding COP

Prostatis Group's COP Position: Q2 2026 in Review

Prostatis Group increased its ConocoPhillips (COP) stake by 67% in Q2 2026, buying an estimated $176K and bringing the position to 3,705 shares worth $385K. The position accounts for 0.09% of the portfolio, ranked #123.

Prostatis Group first reported a position in COP in Q3 2023 and has held it in 6 quarters since. 2,452 funds tracked by Wall St. Rank hold COP as of Q2 2026.

  • Prostatis Group held 3,705 shares of ConocoPhillips worth $385K as of Q2 2026.
  • Prostatis Group bought 1,485 ConocoPhillips shares in Q2 2026, an estimated $176K.
  • ConocoPhillips made up 0.09% of Prostatis Group's portfolio in Q2 2026, its #123 holding.
  • Prostatis Group first reported a position in ConocoPhillips in Q3 2023 and has held it in 6 quarters since.
  • 2,452 funds tracked by Wall St. Rank held ConocoPhillips as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.